Nanoviricides Q2 EPS $(0.18) Down From $(0.15) YoY; As Of December 31, 2023, We Had Cash And Cash Equivalent Current Assets Balance Of Approximately $5.31M. Additional Agreements Have Resulted In A Further Approximately $2.5M Available Cash
Nanoviricides Q2 EPS $(0.18) Down From $(0.15) YoY; As Of December 31, 2023, We Had Cash And Cash Equivalent Current Assets Balance Of Approximately $5.31M. Additional Agreements Have Resulted In A Further Approximately $2.5M Available Cash
Nanoviricides第二季度每股收益为0.18美元（0.18美元），低于同比增长0.15美元；截至2023年12月31日，我们的现金和现金等价物流动资产余额约为531万美元。其他协议又带来了约250万美元的可用现金
Nanoviricides (AMEX:NNVC) reported quarterly losses of $(0.18) per share. This is a 20 percent decrease over losses of $(0.15) per share from the same period last year.
Nanoviricides（美国证券交易所股票代码：NNVC）报告的季度亏损为每股0.18美元。这比去年同期每股亏损0.15美元（0.15美元）下降了20％。